T 1590/17 (Unstructured recombinant polymers/AMUNIX) of 07.05.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T159017.20210507
- Date of decision
- 7 May 2021
- Case number
- T 1590/17
- Online on
- 28 July 2021
- Petition for review of
- -
- Application number
- 11172812.7
- IPC class
- C12N 15/06G01N 33/567G01N 33/53
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Unstructured recombinant polymers and uses thereof
- Applicant name
- Amunix Operating Inc.
- Opponent name
- Novo Nordisk A/S
XL-protein GmbH - Board
- 3.3.01
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 83European Patent Convention Art 111(1)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 15(3)European Patent Convention R 115(2)
- Keywords
- Amendments - allowable (yes)
Sufficiency of disclosure - (yes)
Appeal decision - remittal to the department of first instance (yes) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division for further prosecution.